Latest Articles
Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026 - The Manila Times
Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026 The Manila Times
Published: April 23, 2026, 8:14 p.m.
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) - ACCESS Newswire
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) ACCESS Newswire
Published: April 23, 2026, 12:57 p.m.
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) - News-Press NOW
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) News-Press NOW
Published: April 23, 2026, 12:56 p.m.
JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments | Newswise - Newswise
JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments | Newswise Newswise
Published: April 21, 2026, 1:10 a.m.
Mariam Naqvi, MD, on eliminating bias in hospital toxicology testing - Contemporary OB/GYN
Mariam Naqvi, MD, on eliminating bias in hospital toxicology testing Contemporary OB/GYN
Published: April 20, 2026, 4:29 p.m.
JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments - Roswell Park Comprehensive Cancer Center
JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments Roswell Park Comprehensive Cancer Center
Published: April 20, 2026, 1 p.m.
Feinstein Institutes' ROSE study continues to advance critical endometriosis diagnostic test - SelectScience
Feinstein Institutes' ROSE study continues to advance critical endometriosis diagnostic test SelectScience
Published: April 20, 2026, 8:49 a.m.
High response rates in platinum-resistant ovarian cancer with immunotherapy agents - MSN
High response rates in platinum-resistant ovarian cancer with immunotherapy agents MSN
Published: April 20, 2026, 8:14 a.m.
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer Oncodaily
Published: April 18, 2026, 6:23 p.m.
Lena Dunham and the art monster - New Statesman
Lena Dunham and the art monster New Statesman
Published: April 18, 2026, 1:36 a.m.
Link copied to clipboard!